Covered recipient · General Payments record
MINDY M SANDERS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,645.70
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $613.57 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $391.84 | 3 |
| ABBVIE INC. | $137.91 | 15 |
| Phathom Pharmaceuticals, Inc. | $83.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.06 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140930 | CMS |
| ABBVIE INC. | $4.15 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140932 | CMS |
| ABBVIE INC. | $5.33 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140934 | CMS |
| ABBVIE INC. | $4.55 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140936 | CMS |
| ABBVIE INC. | $6.45 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140938 | CMS |
| ABBVIE INC. | $14.41 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140940 | CMS |
| ABBVIE INC. | $4.55 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140942 | CMS |
| ABBVIE INC. | $5.76 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140944 | CMS |
| ABBVIE INC. | $23.62 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140946 | CMS |
| ABBVIE INC. | $5.22 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140948 | CMS |
| ABBVIE INC. | $5.46 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140950 | CMS |
| ABBVIE INC. | $5.04 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140952 | CMS |
| ABBVIE INC. | $14.99 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140954 | CMS |
| ABBVIE INC. | $5.63 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140956 | CMS |
| ABBVIE INC. | $12.69 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108140958 | CMS |
| Amgen Inc. | $123.26 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117373646 | CMS |
| Amgen Inc. | $123.26 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117373648 | CMS |
| Amgen Inc. | $145.32 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117373650 | CMS |
| Phathom Pharmaceuticals, Inc. | $83.82 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151202933 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.